Fewer AIDS deaths and illnesses: new information. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply. NLM AIDSLINE Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Fewer AIDS deaths and illnesses: new information. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.

AIDS Treat News. 1997 Feb 21;(No 265):1-3. Unique Identifier : AIDSLINE AIDS/97702527
James JS

Abstract: AIDS death rates have fallen to about half of the previous levels among those who have access to new treatment options. Information on survival and hospitalization rates presented at the recent retroviruses conference is summarized. The 48 percent decline in New York City rates for AIDS deaths is attributed to more testing, better care, and adequate Federal and State funding for both care and prevention.
Keywords: AIDS-Related Opportunistic Infections/EPIDEMIOLOGY Acquired Immunodeficiency Syndrome/*ECONOMICS/EPIDEMIOLOGY/ *MORTALITY *Drug Costs Drug Therapy, Combination France HIV Infections/DRUG THERAPY/*ECONOMICS/*MORTALITY HIV Protease Inhibitors/THERAPEUTIC USE Health Services/*UTILIZATION *Health Services Needs and Demand Hospitalization/STATISTICS & NUMER DATA Human Los Angeles/EPIDEMIOLOGY New York City/EPIDEMIOLOGY San Francisco/EPIDEMIOLOGY NEWSLETTER ARTICLEKWDaids-relatedopportunisticinfections/epidemiologyacquiredimmunodeficiencysyndrome/KWDeconomics/epidemiology/KWDmortalityKWDdrugcostsdrugtherapy,combinationfrancehivinfections/drugtherapy/KWDeconomics/KWDmortalityhivproteaseinhibitors/therapeuticusehealthservices/KWDutilizationKWDhealthservicesneedsanddemandhospitalization/statistics&numerdatahumanlosangeles/epidemiologynewyorkcity/epidemiologysanfrancisco/epidemiologynewsletterarticle
970830
M9781224

Copyright © 1997 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .